Related Experiment Video
Updated: Jan 10, 2026
Bacterial Phylum Spirochaetes
Published on: June 12, 2025
Appearance and characterization of lipoprotein X during continuous intralipid infusions in the neonate
Insights
Infants receiving Intralipid for parenteral nutrition developed high phospholipid and cholesterol levels due to exceeded clearance mechanisms, leading to abnormal lipoprotein X (Lp-X) accumulation. Mesophase phospholipids in Intralipid may contribute to this process.
Area of Science:
- Lipid metabolism
- Pediatric nutrition
- Biochemistry
Background:
- Infants requiring total parenteral nutrition often receive Intralipid infusions.
- Intralipid is a lipid emulsion used to provide calories and essential fatty acids.
Purpose of the Study:
- To investigate the development of hyperphospholipidemia and hypercholesterolemia in infants receiving Intralipid.
- To identify the form and origin of accumulated lipids and characterize the abnormal lipoproteins.
Main Methods:
- Continuous infusion of Intralipid in infants for 1-10 days.
- Analysis of plasma lipid concentrations (free cholesterol, phospholipid, cholesterol ester, triglyceride).
- Isolation and characterization of lipoproteins, including Lipoprotein X (Lp-X), using electrophoresis and chromatography.
Main Results:
- Marked increases in plasma free cholesterol and phospholipid concentrations were observed within 24 hours.
- Hyperphospholipidemia was attributed to Intralipid, while endogenous sources contributed to cholesterol increase.
- Lipoprotein X (Lp-X), containing albumin and apolipoproteins, accumulated in low-density lipoproteins and disappeared after infusion cessation.
Conclusions:
- Infant clearance mechanisms for phospholipids are exceeded during Intralipid infusion, causing Lp-X accumulation.
- Mesophase phospholipids in Intralipid may play a significant role in Lp-X formation.
- The study highlights potential lipid metabolism disturbances in infants on parenteral nutrition with Intralipid.
Abstract:
The development of hyperphospholipidemia and hypercholesterolemia was studied in infants that required total parenteral nutrition and given a continuous infusion of Intralipid, (1-4 g/kg body wt per 24 h. Detailed studies were carried out on infusion periods lasting 1-10 d. After 24 h there was a marked increase in plasma free cholesterol (68%) and phospholipid (77%) concentrations. Based on the amount of cholesterol in Intralipid, and the rate of infusion, it was estimated that at least 50% of the plasma cholesterol increment during 64-h infusions was derived from endogenous sources. By contrast, the hyperphospholipidemia could be attributed to the Intralipid as the rise in plasma was calculated to be equivalent to only 16% of the exogenous phospholipid infused. Approximately 10% of the phospholipid in Intralipid was in a triglyceride-free mesophase form with a free cholesterol:phospholipid molar ratio of 0.063. There were no systematic changes in plasma concentrations of cholesterol ester or triglyceride during Intralipid infusions. The increase in free cholesterol and phospholipid was localized in the low density lipoproteins (d = 1.006-1.063 g/ml). The presence of lipoprotein X (Lp-X) in the low density lipoprotein fraction was demonstrated by electrophoresis in agar and by isolation and chemical characterization with hydroxylapatite chromatography. Isoelectric focusing of urea-soluble protein of Lp-X revealed that albumin and apolipoproteins CII and CIII were major components, whereas apolipoprotein E and AI were minor constituents. The abnormal lipoprotein was apparent by 16 h during 64 h of infusion. After 6 d of continuous infusions the free cholesterol in Lp-X was 30+/-10 mg/dl (mean+/-SD), which represents a total Lp-X mass of 90 mg/dl. After cessation of the infusion, Lp-X, as monitored by electrophoresis in agar, disappeared within 72-96 h. Thus, during infusion of Intralipid in infants at rates commonly employed, the capacity of the clearance mechanisms for phospholipid are exceeded, which causes the accumulation of phospholipid and free cholesterol in the form of Lp-X particles. It is suggested that mesophase phospholipids in Intralipid may play a significant role in this process.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease I: Introduction
Bacterial Phylum Spirochaetes
Development of Antibiotic Resistance
Bacterial Phylum Actinobacteria
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...